IP Library Assignment 039398/0069
Patent Assignment
Reel/Frame 039398/0069

Assignment of Assignor's Interest

Recorded: 2016-08-10 Pages: 14
Assignors
RODER, JOANNA
Executed: 2016-07-19
MEYER, KRISTA
Executed: 2016-07-18
GRIGORIEVA, JULIA
Executed: 2016-07-27
TSYPIN, MAXIM
Executed: 2016-07-27
OLIVEIRA, CARLOS
Executed: 2016-07-20
STEINGRIMSSON, ARNI
Executed: 2016-07-20
RODER, HEINRICH
Executed: 2016-07-19
ASMELLASH, SENAIT
Executed: 2016-07-19
SAYERS, KEVIN
Executed: 2016-07-19
MAHER, CAROLINE
Executed: 2016-07-29
Assignee
BIODESIX INC.
2970 WILDERNESS PLACE, SUITE 100, BOULDER, COLORADO, 80301
Covered Property (1)
Predictive test for melanoma patient benefit from antibody drug blocking ligand activation of the T-cell programmed cell death 1 (PD-1) checkpoint protein and classifier development methods
Application: 15/207,825 →
Publication: US 2017/0039345
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest Feb 23, 2018
From: BIODESIX, INC.
To: INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT
Reel/Frame 045022/0976 →
Assignment of Assignor's Interest Aug 14, 2020
From: WEBER, JEFFREY
To: H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC.
Reel/Frame 053498/0417 →
Release of Security Interest Mar 19, 2021
From: INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT
To: BIODESIX, INC.
Reel/Frame 055657/0911 →
Security Agreement Nov 22, 2022
From: BIODESIX, INC.
To: PERCEPTIVE CREDIT HOLDINGS IV, LP
Reel/Frame 061977/0919 →